How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Our online, flexible courses will help you and your team make the most of any opportunity, from anywhere in the world. You can find the best answers in a way that fits your schedule. Dive deep into ...

The General Bulletin is an annually published, point-in-time compilation of the university's departments, degree programs, and requirements, as well as a catalog of courses departments can offer ...